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Abstract
In the dog, previous analyses of major histocompatibility complex (MHC) class I genes suggest a
single polymorphic locus, Dog Leukocyte Antigen (DLA)-88. While 51 alleles have been
reported, estimates of prevalence have not been made. We hypothesized that, within a breed,
DLA-88 diversity would be restricted, and one or more dominant alleles could be identified.
Accordingly, we determined allele usage in 47 Golden Retrievers and 39 Boxers. In each
population, 10 alleles were found; 4 were shared. Seven novel alleles were identified.
DLA-88*05101 and *50801 predominated in Golden Retrievers, while most Boxers carried
*03401. In these breeds DLA-88 polymorphisms are limited and largely non-overlapping. The
finding of highly prevalent alleles fulfills an important prerequisite for studying canine CD8+ T-
cell responses.
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Classical major histocompatibility complex (MHC) class I molecules are widely expressed,
cell surface glycoproteins that regulate the development and function of CD8+ T-cell
responses through the presentation of cytosolic-origin peptide epitopes. In part, these class I
molecules are distinguished from their nonclassical counterparts by extensive
polymorphisms. In humans, for example, there are >1500 alleles at the Human Leukocyte
Antigen (HLA)-A locus, >2000 alleles at the HLA-B locus, and >1000 alleles at the HLA-C
locus (1). Allelic variation, which arises primarily by intra-locus recombination or point
mutation, is frequently concentrated in hypervariable regions (HVRs), where residues of the
heavy chain α1 and α2 domains contact the bound peptide (2). Such variation can have
important consequences. In a murine model, an H-2K allele with differences only in the
peptide-binding determinants was associated with increased diversity of the corresponding
cytotoxic T-cell repertoire and enhanced resistance to viral infection (3). Selection pressure
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from pathogens can act on allelic variation to maintain the polymorphism of classical MHC
molecules (4). Not surprisingly, restricted MHC diversity can have devastating effects on
population survival, as illustrated by the particularly dramatic example of transmissible
facial tumors of Tasmanian devils (5).
In the domestic dog, seven class I loci have been identified in the Dog Leukocyte Antigen
(DLA) complex, and of these, four genes are transcribed: DLA-12, -64, -88 (all on
chromosome 12) and -79 (on chromosome 18) (6, 7). The DLA-88 locus appears to be the
most polymorphic, with 51 published alleles identified from >205 unrelated dogs (8-11).
Variability at the other loci appears much more limited, with two, three and four alleles
described to date for DLA-12, -64 and -79, respectively, from samples obtained from 18-20
dogs (8). While there have been no large scale DLA class I sequencing efforts published so
far, it is reasonable to estimate that the overall pool of diversity in dogs will be much smaller
than in humans, given the potentially low number of founders, and the recency of
domestication, which is too short an evolutionary time to permit the creation of new alleles
in any significant number (12). With some estimations of as few as 50 to 100 founding
wolves (13), the total number of class I alleles at the DLA-88 locus may be no greater than
several hundred in the domesticated dog population. This supposition is consistent with class
II data, with a total of only 100 reported alleles at the most variable locus, DLA-DRB1,
obtained from >1600 dogs (14).
The polymorphisms of MHC molecules constitute a barrier to allotransplantation, and also
represent a substantial obstacle to studying antigen-specific T-cell responses across
unrelated individuals. Advances in understanding cytotoxic CD8+ T-cell activity in
autoimmune, infectious, and neoplastic canine diseases, as well as with immunization or
transplantation, could be expedited by defining frequently occurring class I alleles in
subpopulations of dogs. Breeds are an obvious choice for performing such analyses, as one
would expect allelic diversity to be low, due to the limited number of foundation stock, as
well as the use of inbreeding and overutilization of popular sires. Moreover, the easily
recognized physical characteristics that define breed members could be a convenient means
of identifying dogs that have a potentially high likelihood of sharing alleles or haplotypes.
Indeed, intrabreed variation at several canine class II loci is quite limited (15-17). To date,
however, no assessment of the prevalence of canine MHC class I alleles has been
performed, while in humans, such information is readily available (18). In this investigation,
we hypothesized that, within a breed, DLA-88 polymorphisms would be restricted, and one
or a few alleles would dominate the locus. To examine this prediction, we sought to
determine allelic variation in cohorts of dogs from two popular breeds, Golden Retrievers
and Boxers, using reverse transcription-polymerase chain reaction (RT-PCR) and sequence-
based typing.
For the study, venous blood samples were obtained from unrelated adult dogs (n = 65)
admitted to the North Carolina State University (NCSU) Veterinary Teaching Hospital
(VTH), from volunteer donors (n = 24) recruited through the Clinical Studies Core of the
NCSU Center for Comparative Medicine and Translational Medicine, or from Beagles (n =
2) from the NCSU Laboratory Animal Resources unit. The blood collection protocol was
approved by the NCSU Institutional Animal Care and Use Committee. Peripheral blood
mononuclear cells (PBMCs) were isolated by centrifugation (400 g × 30 min at room
temperature) over a Histopaque 1.077 continuous density gradient (Sigma-Aldrich, St.
Louis, MO). From lysates of PBMCs, or the canine histiocytic cell line DH82 (ATCC
CRL-10389), RNA was purified using an RNeasy Plus Mini Kit (Qiagen, Valencia, CA),
and cDNA was synthesized by RT using an oligo(dT)15 primer.
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Primers for the DLA-88 gene were synthesized by Invitrogen (Carlsbad, CA): exon 1
forward 5′-CGGAGATGGAGGTGGTGA-3′ and exon 4 reverse 5′-
GGTGGCGGGTCACACG-3′. Amplification of cDNA templates was performed using a
high fidelity Advantage-HF 2 PCR Kit (Clontech, Mountain View, CA) on a Mastercycler
Pro thermocycler (Eppendorf, Hauppauge, NY) programmed with the following cycling
conditions: initial denaturation/hot start at 95°C for 3 min, followed by 30 cycles of
denaturation at 95°C for 20 s, annealing at 62°C for 30 s, extension at 68°C for 1 min and 15
s, succeeded by a final elongation step at 68°C for 5 min. All experiments included a
negative control sample in which water was substituted for cDNA. Reaction products were
separated by electrophoresis on a 1% agarose gel, excised, purified, and ligated overnight at
4° C into a pGEM-T Easy Vector (Promega, Madison, WI). Transformed colonies of
chemically competent E. coli (GC10; Genesee Scientific, San Diego, CA) were selected by
blue/white screening, and plasmids were purified by alkaline lysis (QIAprep Spin Miniprep
Kit; Qiagen). Plasmids positive by EcoRI restriction digest were sequenced in both
directions by Eurofins MWG Operon (Huntsville, AL) or Eton Bioscience Inc. (San Diego,
CA), using T7 and SP6 primers. The obtained sequences were compared to all previously
reported alleles of DLA-12,-64, -79, and -88 (8-11) using A plasmid Editor (ApE) software
(19). For dogs with a single allele, a minimum of six colonies were sequenced; for
heterozygotes, a minimum of two colonies were sequenced, if the alleles had been described
previously. Sequences of novel alleles were determined from a minimum of six colonies,
which were obtained from two or more different animals whenever possible, to insure that
the observed allele was not due to PCR or sequencing error. Names for new alleles were
assigned according to published conventions of the Comparative MHC Nomenclature
Committee (20) by the curator (LJ Kennedy) of the canine IPD-MHC database.
We designed primers to anneal to exons 1 and 4 of the DLA class I heavy chain to provide
full-length sequence data for exons 2 and 3, which encode the α1 and α2 domains that
contain the antigen recognition site (ARS) for the T cell receptor. In genotyping HLA-A, B
and C alleles, nucleotide sequences from exons 2 and 3 can unambiguously assign allelic
identity in virtually all (>99.9%) cases (2), and accordingly, we used this approach in our
study. Because of the high degree of homology between exons of the four transcribed MHC
class I loci, it was not possible to produce individually specific forward and reverse primers
for DLA-88 amplification from cDNA. To circumvent this difficulty, the forward primer
was designed to anneal to the DLA-64 and -88 loci, while the reverse primer was designed
to anneal to the DLA-12 and -88 loci. To confirm the ability of the primer pair to
exclusively amplify transcripts from the DLA-88 locus, we first tested cDNA from the
canine cell line DH82, from which only a single DLA-88 allele had been found previously
(21); although unnamed, our analysis suggested that this sequence most likely represented
DLA-88*50801 (with 2 bp substitutions). Cloning of the ∼650 bp amplimer yielded two
sequences: DLA-88*50801 and a putative new allele (now DLA-88*05101). Because the
locus of origin of the second allele could not be definitively established by reference to
DLA-88 sequences in the canine IPD-MHC database, however, we repeated our evaluation
of the primer set using cDNA from PBMCs isolated from a Beagle. As most reported alleles
of DLA-88 have been obtained from Beagles or Beagle mixes (9, 11, 22), the likelihood of
identifying another novel DLA-88 allele was presumed to be low. Indeed, only the
previously reported allele DLA-88*50201 was sequenced in 23 colonies from this dog,
indicating that amplification from the other class I loci – DLA-12,-64, and -79 – was highly
unlikely with our set of primers. To provide further support for this conclusion, we then
amplified cDNAs from four additional Beagles; again, only established DLA-88 alleles were
identified in these analyses (DLA-88*00401, *00501, *00601, *50101, *50201).
We then sought to determine whether frequently shared alleles of DLA-88 could be
identified within a breed. To accomplish this objective, we compared nucleotide sequences
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for exons 2 and 3 from 47 Golden Retrievers. From this population, a total of 10 alleles were
obtained; the relative frequencies are shown in Table 1. Four novel alleles –
DLA-88*01202,*02101,*03301 and *05101 – were found (Table 2). The most prevalent
allele was DLA-88*50801. Together with DLA-88*05101, these two variants constituted
58% of the total allelic pool. When the frequency of occurrence was calculated on a per-dog
basis, DLA-88*05101 was the most commonly encountered allele (Table 1, right column);
the difference in prevalence between these two measures is attributable to the greater
number of homozygotes among dogs possessing DLA-88*50801 (n = 11) than those with
DLA-88*05101 (n = 4). Of the Golden Retrievers carrying the remaining eight alleles, only
four homozygotes were identified. Not surprisingly, the DH82 cell line, which was derived
from a Golden Retriever in Ohio in the mid-1980s (23), possessed the two most common
alleles of the breed.
To demonstrate that the finding of a few dominant class I alleles was not peculiar to Golden
Retrievers, we performed the same analysis with another breed, the Boxer. Among these
dogs (n = 39), 10 DLA-88 alleles were again found; of these, only 4 were also common to
Golden Retrievers (Table 1, bold face alleles). DLA-88*03401 constituted 50% of alleles in
the total pool (Table 1, middle column) and was present in 82% of Boxers (right column).
Seven dogs were homozygous for DLA-88*03401, while for all other nine alleles, only
seven homozygote animals were identified. Four of the alleles found in Boxers are new:
DLA-88*02803,*02901,*03201 and *05101 (Table 2).
Interestingly, during our analysis of Boxers, we observed that one dog appeared to have
three DLA-88 alleles. To rule out contamination as a possible source of this finding, RNA
was isolated from a second blood sample from this dog; genotyping again revealed the same
three alleles. Ultimately, 7 of the 39 Boxers (5 males, 2 females) were observed to possess
three different alleles. To our knowledge, none of these dogs had received a blood
transfusion. Maternal microchimerism has been documented to result in the recovery of non-
inherited HLA alleles from the PBMCs of healthy adults (24); however, this seems an
unlikely cause, given the phenomenon was confined to Boxer dogs, and all of the
individuals had the identical triplet combination: DLA-88*02803, *02901 and *03401 (note:
in subsequent work, we have observed a few other combinations, but these always have
contained either DLA-88*02803 or *02901 or both [Ross P, unpublished observations]).
Therefore, we also considered the possibility that our primer pair had amplified sequences
from other class I loci. Given that DLA-12, -64 and -79 are minimally polymorphic, one
would predict such off-target amplification to occur in a majority of the dogs, however, not
simply in a small subset of one breed. Moreover, sequence analysis strongly supports
DLA-88 as the locus of origin for the two novel alleles, *02803 and *02901 (*03401 has
been previously established), as pairwise identity of exons 2 and 3 of either allele with
DLA-88*00101 is 97%, but only 82% with DLA-64 and 76% with DLA-79. The DLA-12
and -88 loci have far greater homology of exons 2 and 3, making this comparison much less
useful; however, exon 1 sequences (encoding the leader peptide) are substantially disparate
(6). Accordingly, we analyzed exon 1 sequences from *02803 and *02901, and found 100%
identity with DLA-88. Nor do any of the three alleles appear to be pseudogenes, as all had
open reading frames when sequenced through the transmembrane domain (data not shown).
It should be stated that other investigators also have found three DLA-88 alleles specifically
in dogs of the Boxer breed (LJ Kennedy, personal communication, University of
Manchester, Manchester, UK). Additionally, dogs possessing three DQB1 alleles (with an
analogous breed bias - Samoyeds) have been reported (14). For both loci – DLA-88 and -
DQB1 – it is likely that this phenomenon is due to gene duplication, which has been found
in the MHC of other species, such as the horse and cow (25, 26).
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The alignment of the predicted amino acid sequences of the α1 and α2 domains of the seven
novel alleles identified in Golden Retrievers and Boxers is shown in Figure 1. As expected,
most of the amino acid variability is found in the defined HVRs (2). Outside of the HVRs,
all amino acid differences identified in the new sequences, with the exceptions of pro 43, arg
50, glu 61 and glu 62 in DLA-88*05101, have been observed in at least one other allele. Of
the 19 α1 and α2 residues in the β sheet of HLA-A2 that interact with β-2 microglobulin
(27), sixteen are conserved across these canine alleles (Supplemental Figure 1). Similarly,
all nine amino acids in the peptide binding region that are conserved in human and mouse
classical class I molecules (27) are present, as are the cysteine residues that form the
disulfide linkage between the α2 helix (cys 164) and the floor of the binding groove (cys
101) (28). Additionally, all of these new alleles have exon 1 sequences that align with the
DLA-88 locus (data not shown). It is also worthy of note that, during this investigation,
three additional sequences that were putative DLA-88 alleles were found (Supplemental
Table 1); however, we were unable to obtain a sufficient number of colonies to validate
these sequences.
To investigate the relationship of the new alleles with those that have been previously
reported (8-11), we created a phylogenetic tree of all nucleotide sequences (Figure 2),
analogous to such analyses of class I alleles in other species (29-31). As expected, the new
alleles (marked by arrows) followed branch points that led to tight clustering with other
known DLA-88 sequences. Further, these alleles are interspersed throughout the tree,
consistent with the known creation histories for these relatively young (mid-to-late 19th
century) breeds from disparate founders (wavy-coated Retriever, Tweed Water Spaniel, Irish
setter, Bloodhound, and the St. John's Water Dog for the Golden Retriever; the
Bullenbeisser and the English bulldog for the Boxer) (32, 33).
Across species, a common characteristic of classical MHC class I molecules is the finding of
positive selection of amino acid sites in the ARS (30, 31, 34, 35). We therefore evaluated all
58 DLA-88 nucleotide sequences – the 7 alleles from this study and the 51 alleles previously
described – for evidence of positive selection using Bayesian analysis. Five codons in the
α1/α2 domains with a mean probability >95% of being positively selected were identified:
73, 95, 114, 152 and 156. To assess the potential biologic relevance of these findings, we
used the crystal structure of HLA-A*1101 to generate a 3-D model of one highly prevalent
canine allele, DLA-88*03401, which is depicted in Figure 3. From this modeling, it can be
seen that all of the positively selected sites are predicted to occur in the ARS (specifically,
the peptide binding groove) of this class I molecule.
Bottlenecks in population size – in this case, due to breed founding some 50 to 75
generations ago – result in the loss of genetic variation at polymorphic loci, which is seen as
decreased allele numbers and heterozygosity (36). For example, marked restrictions in class
I polymorphisms due to selective breeding are evident in miniature swine (30). To compare
the allelic variation present in our sample groups, we used the Shannon entropy as an index
of diversity. The Shannon entropy is a member of the family of valid diversity indices that
equally rates species richness and clonal dominance (37). Entropy was estimated with
correction for unseen species and inference of confidence intervals, as previously described
by our group (38), which allows the statistical significance of entropy comparisons to be
evaluated. Allelic diversity was not statistically different between Golden Retrievers (1.78,
95% confidence intervals [CI] 1.60 – 1.96) and Boxers (1.75, 95% CI 1.52 – 1.98); both
populations were under-sampled for comprehensive discovery of all possible alleles (data
not shown), as determined by the method of Egeland and Salas (39). Although the total
number of alleles in the populations is unknown, this value can be estimated from the
observed allele distributions. When this computation is performed using a non-parametric
estimator (40), as implemented in the software package SPADE (41), the calculated number
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of DLA-88 alleles (and 95% CI) in the Golden Retriever and Boxer populations are 11.5
(10.1 – 25.1), and 10.3 (10.0 – 14.8), respectively. These values represent a level of allelic
diversity at this classical MHC class I locus far less than that of humans, and suggest that
our experiment was successful in recovering the major alleles from each population.
The finding of limited intrabreed diversity at the DLA-88 locus is not unexpected, as
previous investigations of MHC class II allelic variation show analogous restrictiveness. For
example, at the DLA-DRB1 locus, only 8 alleles were found in 31 Golden Retrievers, with 3
alleles (DLA-DRB1*01201, *01501 and *02001) being dominant (14). Similarly, 5 DLA-
DRB1 alleles were observed in 41 Boxers; 71% shared the DLA-DRB1*00401 allele. The
magnitude of DLA-88 restriction likely varies with breed. That Boxers have a single,
dominant allele – DLA-88*03401 – while Golden Retrievers do not is presumably the result
of a less severe bottleneck in the latter breed (42). Therefore, breeds with very few founders,
such as the Basenji, Doberman, or Irish wolfhound, would be expected to carry few alleles.
On the other hand, Beagles appear to have more class I variability. When the prevalence
data from the 5 dogs in this study is combined with sequence-based typed Beagles in the
literature (n = 6)(22) and (n = 2)(10), 10 different alleles (DLA-88*00101, *00401, *00402,
*00501, *00601, *01602, *04501, *50101, *50201 and *50801) are observed in just 13
dogs. Interestingly, when diversity is calculated for the Beagle population, the confidence
interval of the entropy estimation crosses that of the Golden Retriever and Boxer
populations, although the interval is quite wide. This observation might be explained by
increased species richness (more alleles) in Beagles in the setting of less equally distributed
alleles, but additional work would be necessary to confirm this hypothesis. As a second
measure of decreased intrabreed genetic variation at the DLA-88 locus, we also observed
high levels of homozygosity in the sample dogs: 38.3% in Golden Retrievers; 35.9% in
Boxers. While it is possible that our primer set failed to amplify some alleles, causing an
overestimation of homozygosity, this seems less likely, as none of the 91 dogs in this study
failed to return a DLA-88 sequence. Moreover, our data is consistent with the range of MHC
homozygosity (33-40%) measured at the DLA-DRB1, -DQA1 and -DQB1 loci in several
studies (14, 15).
As one might anticipate, interbreed variability for DLA-88 was high. Thus, of the 10
DLA-88 alleles identified in each breed, only 4 were shared, reflecting the different founders
and genetic separation of these breeds. Moreover, the frequency distribution of alleles was
dissimilar. For example, the two most commonly occurring variants in Golden Retrievers,
DLA-88*05101 and *50801, had a prevalence of only 9.4% and 2.4%, respectively, in
Boxers, while DLA-88*03401 was not observed in any Golden Retriever, despite being
found in 82% of Boxers. Additionally, neither breed possessed two of the alleles that were
present in our small sample of Beagles (DLA-88*00402 and *50201). These data suggest
that the discovery of novel DLA-88 alleles could be expedited by genotyping dogs from
different breeds, particularly by obtaining samples across genetic clusters (43), as has been
done for canine class II (14).
The small sets of DLA-88 polymorphisms found in comparatively large cohorts of dogs
allowed us to estimate the potential total number of alleles in these breed populations,
which, as described above, appears unlikely to exceed 25 in Golden Retrievers and 15 in
Boxers. An important caveat to this conclusion is that many (but not all) of the animals
evaluated in this study came from a relatively restricted geographic location in the
southeastern United States. In humans, it is well established that for polymorphic genes,
such as HLA class I and II, the prevalence of alleles can vary widely by region (18). Hence,
by sampling from a limited area, we may have underestimated allelic diversity. Comparisons
of variability at class II loci between European and North American dogs of the same breeds
do reveal similar allele prevalence and dominant species (15, 16), but a few non-shared
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alleles are also observed. Thus, genotyping Golden Retrievers and Boxers from other
regions ultimately will be useful to corroborate our findings. Nor could we strictly verify
that all dogs were unrelated. The majority of samples, however, were obtained from the
NCSU-VTH, which is a large (>20,000 accessions per year) veterinary referral center for
North Carolina, Virginia, South Carolina, and Tennessee, and therefore, most dogs were
very unlikely to be related. For Boxer samples obtained from a regional breed association (n
= 9), for whom pedigrees were available, none of the dogs had a common sire or dam in >4
generations. Conversely, while all dogs in this study appeared to be purebred by visual
inspection (performed by one of the authors, PRH), we did not verify lineage in all
individuals, and undocumented outbreeding could have led to an overestimation of class I
diversity.
The restricted intrabreed diversity at the DLA-88 locus found in this investigation suggests
that it may be practical to study antigen-restricted CD8+ T-cell responses by screening dogs
drawn from these easily recognizable subsets for highly prevalent allele usage. There are
also well-documented associations of breeds with predispositions to particular diseases,
including those modulated or mediated by the immune system – infectious diseases, cancer,
and autoimmunity – and ultimately, it may be possible to correlate specific DLA-88 variants
with susceptibility or resistance, as has been accomplished with canine class II alleles
(44-50). Lastly, peripheral hematopoietic stem cell transplantation is becoming an
increasingly utilized treatment for canine lymphoma (51), and the limited diversity within
breeds will undoubtedly facilitate haplotype matching to advance the use of allogeneic
donors for this therapy.
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Alignment of the predicted amino acid sequences of exons 2 and 3 (marked by red bars) for
seven novel DLA-88 alleles found in the study populations. Residues in light gray indicate
identities with the reference sequence DLA-88*00101 (top), while those in dark gray
indicate differences. The three HVRs are shown by the blue bars. For the naming of alleles,
sequences with nucleotide differences that resulted in amino acid substitutions within any of
the HVRs were designated as a new major type, (indicated by the first three digits), while
sequences in which substitutions were confined to areas outside the HVRs were considered
novel subtypes and numbered accordingly (last two digits).
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Phylogram of relationships between all known DLA-88 alleles. The seven new alleles
identified in Golden Retrievers (GR) and Boxers (B) are indicated by the arrows. The tree
was constructed with Geneious v.5.1 (52) from the concatenated nucleotide sequences of
exons 2 and 3 on the basis of Tamura-Nei genetic distances (53), using the neighbor-joining
method (54), and was rooted by the inclusion of HLA-A*0101 (GenBank AJ278305) as an
outgroup. The numbers to the left of the internodes are the percentage of supporting
bootstrap (n = 1000) replications; for clarity, only values ≥40 are shown. The units for the
scale bar are the number of nucleotide substitutions per site.
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Schematic representation of DLA-88*03401 (α1 and α2 domains) showing positively
selected amino acid sites. Nucleotide sequences of exons 2 and 3 from all DLA-88 alleles
were aligned by codons and analyzed in two parallel runs using the software program
MrBayes 3.1.2 (55). In each run, 1.0 × 106 cycles were performed. Posterior probabilities for
each amino acid site were analyzed using the Tracer 1.5 program (56); codons were
presumed to be under positive selection when posterior probability values exceeded 0.95.
The burn-in value was set to the first 10% of cycles for each run. The proposed model is
based on the high-resolution crystal structure of HLA-A*1101 (57), and was generated using
SWISS-MODEL (58-60). Views show onto (A) and along (B) the peptide binding groove of
the heavy chain (gray). Positively selected sites are indicated in red, with side chains shown
in yellow. The first residues of the α1 domain (1) and α2 domain (91) are shown in teal.
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Table 1
Prevalence of DLA-88 alleles by breed
Golden Retriever (n = 47)











Boxer (n = 39)











Alleles common to both breeds are shown in bold type.
a
Numbers indicate percentage. Homozygote dogs were considered to possess two copies of the allele.
b
The percentage of dogs with the indicated allele.
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Table 2
Novel DLA-88 alleles in the study populations
Allele Number of clones Number of dogs Breeda GenBank accession
*05101 101 24 B; GR HQ340121
*02803 29 11 B HQ340113
*02901 23 11 B HQ340112
*02101 18 6 GR HQ340114
*01202 17 4 GR HQ340115
*03301 8 2 GR HQ340117
*03201 8 1 B HQ340116
a
B, Boxer; GR, Golden Retriever
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